Joseph A. Burlison

Novobiocin:  Redesigning a DNA Gyrase Inhibitor for Selective Inhibition of Hsp90

Joseph A. Burlison, Len Neckers, Andrew Smith et al. · Journal of the American Chemical Society · 2006 · 243 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative Activity

Alison C. Donnelly, Jared R. Mays, Joseph A. Burlison et al. · The Journal of Organic Chemistry · 2008 · 153 citations · Full text

Medicine, Oncology, Pharmacology +10

The <scp><i>Y</i></scp><i>ersinia pestis</i> siderophore, yersiniabactin, and the <scp>ZnuABC</scp> system both contribute to zinc acquisition and the development of lethal septicaemic plague in mice

Alexander G. Bobrov, Olga Kirillina, Jacqueline D. Fetherston et al. · Molecular Microbiology · 2014 · 148 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

Development of Novobiocin Analogues That Manifest Anti-proliferative Activity against Several Cancer Cell Lines

Joseph A. Burlison, Christopher Avila, George Vielhauer et al. · The Journal of Organic Chemistry · 2008 · 134 citations

Medicine, Medicinal Chemistry, Pharmacology +11

A non-toxic Hsp90 inhibitor protects neurons from Aβ-induced toxicity

Sabah Ansar, Joseph A. Burlison, M. Kyle Hadden et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 114 citations

Life Sciences, Neuroscience, Pharmacology +14